Table 1.
Frequency of the Research Diagnostic Criteria of Temporomandibular Disorders (RDC/TMD)-based diagnosed of temporomandibular joint (TMJ) status, function-dependent tests, and of Axis II findings including sleep bruxism (SB) and awake bruxism (AB) in Lyme patients and control group.
| Lyme Patients | Control | p = Value | |||
|---|---|---|---|---|---|
| IIA | 8 | 10.5% | 7 | 12.96% | p = 1 |
| IIB/IIC | 0 | 0,0% | 0 | 0.0% | p = 1 |
| IIIC | 13 | 17.1% | 3 | 5.6% | p < 0.001 |
| MMP and/or MAP | 14 | 18.4% | 4 | 7.4% | p = 0.059 * |
| SB | 16 | 21% | 7 | 12% | p = 0.234 |
| AB | 17 | 22.4% | 9 | 16.7% | p = 0.423 |
| SOM | 56 | 73.7% | 4 | 7.4% | p < 0.001 |
| GCPS | 12 | 15.8% | 0 | 0.0% | p = 0.002 |
| DEP | 42 | 55.3% | 4 | 7.4% | p < 0.001 |
| OPJ | 35 | 46% | 8 | 14.8% | p < 0.001 |
| tinnitus | 41 | 53.9% | 2 | 3.7% | p < 0.001 |
| HM | 49 | 64.5% | 6 | 11.1% | p < 0.001 |
Disc displacement with reduction (IIA); disc displacement without reduction with limited mouth opening (IIB); disc displacement without reduction, without limited opening (IIC); osteoarthrosis (IIIC); mainly myogenous pain (MMP) and/or mainly arthogenous pain (MAP); sleep bruxism (SB); awake bruxism (AB); moderate/severe somatisation (SOM); high levels of chronic pain-related impairment (GCPS); moderate/severe depression (DEP); other painful joints (OPJ); tinnitus; headaches or migraines (HM).* Fisher exact test.